Inactive Instrument

Other languages LivaNova PLC London S.E.

Equities

LIVN

GB00BYMT0J19

Real-time Estimate Cboe BZX Other stock markets 14:12:52 2024-07-05 EDT			5-day change	1st Jan Change
52.72 ^USD	0.00%		+0.64%	+8.54%

06-13	Daniel Jeffrey Moore Resigns as Director of LivaNova PLC	CI
06-11	Transcript : LivaNova PLC - Shareholder/Analyst Call

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Daniel Jeffrey Moore Resigns as Director of LivaNova PLC	06-13
Sector Update: Health Care Stocks Higher in Late Afternoon Trading	06-06
Sector Update: Health Care Stocks Advance Thursday Afternoon	06-06
LivaNova's VNS Therapy Study for Treatment-Resistant Depression in Unipolar Patients Fails to Achieve Primary Endpoint	06-06
LivaNova PLC Provides Update on Recover Clinical Study Evaluating Vns Therapy for Treatment-Resistant Depression in Unipolar Patients	06-06
Livanova Insider Sold Shares Worth $3,403,694, According to a Recent SEC Filing	06-05
LivaNova's Q1 Adjusted Earnings, Revenue Rise, Tops Street View; Raises 2024 Guidance	05-01
LivaNova PLC Provides Earnings Guidance for the Full-Year 2024	05-01
LivaNova PLC Reports Earnings Results for the First Quarter Ended March 31, 2024	05-01
LivaNova PLC Announces Ahmet Tezel, Ph.D., as Chief Innovation Officer	04-30
Sector Update: Health Care Stocks Ease Late Afternoon	03-20
Sector Update: Health Care Stocks Down Wednesday Afternoon	03-20
LivaNova Says Sleep Apnea Study Likely to Meet Primary Efficacy Endpoint; Shares Jump	03-20
LivaNova PLC Announces a Positive Predictive Outcome of Trial Success in its OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea	03-20
LivaNova Proposes $300 Million Private Placement of Notes	03-04
LivaNova's Q4 Adjusted Earnings, Revenue Increase; Sets 2024 Guidance	02-21
LivaNova PLC Reports Earnings Results for the Full Year Ended December 31, 2023	02-21
Livanova plc Provides Earnings Guidance for the Full-Year 2024	02-21
LivaNova PLC Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-21
LivaNova Names Vladimir Makatsaria as Chief Executive	02-05

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages LivaNova PLC London S.E.

Equities

LIVN

GB00BYMT0J19

Other languages

Filters